Analyst Research
| Report Title | Price |
|---|---|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Finlabo SIM Spa
|
$58.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Sorin SpA Issues Q4 2012 Revenues Guidance Above Analysts' Estimates
Sorin SpA announced that it expects revenues of EUR 185-190 million for the fourth quarter of the fiscal year 2012. The Company estimates that the product segments impacted by the earthquakes would have generated, under normal conditions, additional revenues of approximately EUR 20 million. According to I/B/E/S Estimates, analysts on average are expecting the Company to report for the fourth quarter of the fiscal year 2012, revenues of EUR 167 million.
Latest Developments for Sorin SpA
- Sorin SpA Announces FDA Approval and U.S. Launch OF SMARTVIEW Remote Monitoring Solution for Patients with Implanted Cardiac Defibrillators
- Sorin SpA Receives Approval of Its Investigational Device Exemption (IDE) Application and Clinical Trial
- Sorin SpA Issues Q2 FY 2013 Net Profit Guidance
- Sorin SpA Comments on FY 2013 Net Profit Guidance and Q1 FY 2013 Revenues Guidance
Latest Key Developments in Medical
- Given Imaging Ltd Announces New Data Highlighting PillCam COLON Comparability To Colonoscopy In Detecting Adenomas
- Ossur hf Acquires TeamOlmed in Sweden
- Medtronic Inc Receives 'CE' Mark for 'Export Advance' Aspiration Catheter
- Meade Instruments Corp Announces Merger Agreement; To Be Acquired By Jinghua Optics & Electronics
- Share this
- Link this
- Digg this
Follow Reuters